"Described the effect reduced dose interferon-alpha 2a with bevacizumab in patients with metastatic cell carcinoma." . . "Delva, R." . "McKendrick, J." . "15"^^ . "7"^^ . "19" . "Filipek, M." . . . "Described the effect reduced dose interferon-alpha 2a with bevacizumab in patients with metastatic cell carcinoma."@en . . "368119" . "Annals of Oncology" . . "Sevin, E." . "abtiangiogenic therapy; bevacizumab; interferon-alpha; renal cell carcinoma; vascular endothelial growth factor (VEGF)"@en . "Kombinace bevacizumabu s d\u00E1vkami interferonu-alfa 2a u pacient\u016F s karcinomem ledvin"@cs . "Bracarda, S." . "First-line bevacizumab combined with reduced dose interferon-alpha 2a is active in patients with metastatic renal cell carcinoma" . . . "Melichar, Bohuslav" . "First-line bevacizumab combined with reduced dose interferon-alpha 2a is active in patients with metastatic renal cell carcinoma"@en . "0923-7534" . "000258136800017" . "Ravaud, A." . . "RIV/00216208:11150/08:00107075!RIV09-MZ0-11150___" . "Santoro, A." . "Koralewski, P." . "Pisa, P." . . "First-line bevacizumab combined with reduced dose interferon-alpha 2a is active in patients with metastatic renal cell carcinoma"@en . "Z(MZ0FNHK2005)" . . "Escudier, B." . "11150" . "[7603BDC81442]" . "1"^^ . "Pluzanska, A." . . "RIV/00216208:11150/08:00107075" . . . "Negrier, S." . . "GB - Spojen\u00E9 kr\u00E1lovstv\u00ED Velk\u00E9 Brit\u00E1nie a Severn\u00EDho Irska" . "First-line bevacizumab combined with reduced dose interferon-alpha 2a is active in patients with metastatic renal cell carcinoma" . "Chevreau, C." . . "Kombinace bevacizumabu s d\u00E1vkami interferonu-alfa 2a u pacient\u016F s karcinomem ledvin"@cs . "Szczylik, C." . "Pops\u00E1n efekt redukce d\u00E1vky interferonu na \u00FA\u010Dinnost v kombinaci s bevacizumabem u karcinomu ledvin."@cs . . "8" . .